This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fox, J. J. et al. Positron emission tomography/computed tomography–based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer. JAMA Oncol. http://dx.doi.org/10.1001/jamaoncol.2017.3588 (2017)
Rights and permissions
About this article
Cite this article
Kelsey, R. Glycolysis and AR expression as biomarkers. Nat Rev Urol 15, 2 (2018). https://doi.org/10.1038/nrurol.2017.205
Published:
Issue date:
DOI: https://doi.org/10.1038/nrurol.2017.205